Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1989
12/20/1989EP0347143A2 Nlteration of the interaction of a T-cell receptor with a protein-tyrosine kinase
12/20/1989EP0347057A1 Method of treating myeloid leukemias
12/20/1989EP0346430A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis
12/20/1989EP0346370A1 Synthetic anti-caries vaccine
12/19/1989US4888414 Insulin-binding peptides and uses thereof
12/19/1989US4888275 Diagnosing and monitoring cancer
12/19/1989US4888169 Inactivating cells with glutaraldehyde
12/19/1989CA1264000A1 Antigenic modification of polypeptides
12/14/1989WO1989012095A1 A method of evaluating recombinant vaccines against immunodeficiency virus
12/14/1989WO1989012094A1 Hiv-3 retrovirus and its use
12/14/1989WO1989012093A1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
12/14/1989WO1989011876A1 Radiohalogenated compounds for site specific labeling
12/14/1989WO1989011869A1 Antibody modified with toxin
12/14/1989WO1989011867A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles
12/14/1989WO1989011866A1 A pharmaceutical preparation and a conjugate of a bactericide and an antibody directed against plaque forming or caries-inducing bacteria
12/14/1989WO1989011865A1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
12/14/1989WO1989011864A1 Method of treating myeloid leukemias
12/14/1989WO1989009601A3 Monosaccharides or polysaccharides used as antiviral agent
12/14/1989DE3819804A1 Synthetic peptide epitopes of the HIV coat protein
12/13/1989EP0346087A2 Hybrid antibody and process for the production thereof
12/13/1989EP0346078A2 Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
12/13/1989EP0346022A1 Peptide fragments of HIV
12/13/1989EP0345911A1 Canine coronavirus
12/13/1989EP0345867A1 Novel synthetic, immunologically active peptides useful for the preparation of antimalarial vaccines
12/13/1989EP0345811A2 Monoclonal abtibodies specific for human fibrinopeptide A
12/13/1989EP0345726A2 Plastin isoforms and their uses
12/13/1989EP0345549A2 Removal of protein A from antibody preparations
12/13/1989EP0345543A2 Therapeutic IgM concentrates
12/13/1989EP0345461A2 Mouse monoclonal antibodies to HIV-1P24 and their use in diagnostic tests
12/13/1989EP0345375A1 HIV-3 retrovirus and its use
12/13/1989EP0345318A1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids
12/13/1989EP0345315A1 Ps2 protein derivative
12/13/1989EP0345299A1 Mycobacterium tuberculosis genes encoding protein antigens
12/13/1989EP0345260A1 Method of treatment of mammals using antibodies to early pregnancy factor (epf)
12/13/1989EP0179127B1 Leukoregulin, an antitumor lymphokine, and its therapeutic uses
12/13/1989CN1037925A Monoclonal antibodies
12/13/1989CN1037838A Live combination vaccine
12/12/1989US4886836 Activated medium with low non-specific protein adsorption
12/12/1989US4886782 T-cell epitope of circumsporozoite protein of plasmodium
12/12/1989US4886779 Inactivation of human immunodeficiency virus (HIV) in protein-containing solutions by phenols
12/12/1989US4886758 Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances
12/12/1989US4886663 Having at least one disulfide bond
12/06/1989EP0345021A2 Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
12/06/1989EP0344955A2 Novel long-chain glycolipid structure
12/06/1989EP0344940A2 Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
12/06/1989EP0344872A1 Vaccine composition
12/06/1989EP0344864A2 Method for producing nonhyperglycosylated hepatitis B virus protein
12/06/1989EP0344808A1 Recombinant coccidiosis vaccines
12/06/1989EP0344586A2 Medicine containing a TNF inhibitor
12/06/1989EP0344320A1 Human monoclonal antibody against candida
12/06/1989EP0344257A1 RHOPTRY ANTIGEN OF $i(PLASMODIUM FALCIPARUM)
12/06/1989EP0344211A1 Monoclonal antibodies in vaccine formulations
12/05/1989US4885359 Adsorption on cellulose sulfate or crosslinked polysaccharide sulfate gel
12/05/1989US4885166 Hybrid interferons
12/05/1989CA1263618A1 Hybrid particle immunogens
12/05/1989CA1263598A1 In vitro detection of gastrointestinal cancer
11/1989
11/30/1989WO1989011547A1 Method for hla dp typing
11/30/1989WO1989011538A1 Platelet-specific chimeric immunoglobulin
11/30/1989WO1989011537A1 Antibodies
11/30/1989WO1989011534A1 Mumps virus hemagglutinin-neuraminidase
11/30/1989WO1989011491A1 Antibodies to human mammary cell growth inhibitor and methods of production and use
11/30/1989WO1989011489A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto
11/30/1989WO1989011298A1 Formulation for antibody reagents
11/30/1989WO1989011297A1 Freeze-dried formulation for antibody products
11/30/1989WO1989011296A1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
11/30/1989WO1989011288A1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells
11/30/1989WO1989011287A1 Induction of tolerance to a foreign antigen
11/30/1989WO1989011285A1 Diagnostics and therapy for rheumatoid arthritis
11/30/1989WO1989011273A1 Adhesion receptor for laminin and its use
11/30/1989WO1989011270A1 Liposomes coupled to hormones
11/29/1989EP0344139A2 Tumor diagnostic method
11/29/1989EP0344006A2 Peptides that block the binding of hiv-1 to th CD4 receptor protein
11/29/1989EP0343548A2 Antigen solution containing a polyalphaolefin (PAO), process for its preparation and use of PAO as an adjuvant
11/29/1989EP0343544A2 Immunostimulating substance from propioni bacteria, and process for its production
11/29/1989EP0343480A1 Use of interleukin-2 in the immunostimulation of weakened immune reaction
11/29/1989EP0343479A1 Combination of human immunoglobulins and interleukin-2 for combating infection diseases
11/29/1989EP0343460A2 P. falciparum CS-peptides as universal T-cell epitope
11/29/1989EP0343186A1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY -i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM.
11/28/1989US4883790 Use of hydro-monobenzoporphyrins to mediate the destruction of unwanted cells or tissues by irradiation
11/28/1989US4883761 Pertussis toxin gene: cloning and expression of protective antigen
11/28/1989US4883752 Hepatitis b surface antigen
11/28/1989CA1263324A1 Method for selecting hybridomas producing antibodies specific to inaccessible cell surface antigens
11/28/1989CA1263308A1 Klebsiella capsular polysaccharide vaccine
11/28/1989CA1263307A1 Polydisperse native pseudomonas flagellar (h) antigens and a method of producing them
11/28/1989CA1263306A1 Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
11/28/1989CA1263305A1 Oral vaccines
11/23/1989EP0343137A1 Fibronectin binding protein
11/23/1989EP0342564A2 Method for the production of a test antigen for the diagnosis of bovine herpes virus type 1 (BHV 1) infection
11/22/1989CN1037276A Products with autibody activity and broad-spectrum action pharmaceutical composed of them or containing them, and their use
11/21/1989US4882424 Activation antigen
11/21/1989US4882317 Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
11/21/1989US4882278 Immunological protection against cholera
11/21/1989US4882271 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
11/21/1989US4882270 Monoclonal antibodies to placental isoferritin for use in detecting oncofetal ferritin associated with breast cancer and Hodgkins disease
11/21/1989US4882145 T cell epitopes of the hepatitis B virus nucleocapsid protein
11/16/1989WO1989010967A1 Recombinant flagellin vaccines
11/16/1989WO1989010966A1 Vectors encoding hcmv glycoprotein and expression products
11/16/1989WO1989010965A2 Glycoprotein h of herpes viruses
11/16/1989WO1989010961A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
11/16/1989WO1989010939A1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens
1 ... 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 ... 1823